Aditya Birla Sun Life AMC
- Market Cap
- ₹27,069 Cr
- P/E
- 27.39
Key Fundamentals
SmallcapCapital MarketsFinancial ServicesPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 32.20%
- Debt to Equity
- 0.02
- EPS (TTM)
- ₹34.15
- Book Value
- ₹134.16
- Market Cap
- ₹27,069 Cr
- P/E (TTM)
- 27.39
- P/B
- 6.97
- ROE
- 25.20%
- Dividend Yield
- 2.73%
- EBITDA
- ₹1,319 Cr
- 52W High
- ₹1,224.90
- 52W Low
- ₹708.00
- Day Range
- ₹926.25 – ₹943.00
- Volume
- 1,01,954
Peer Comparison
Financial Services › Capital Markets › Asset Management Company
| 2,961.40 | 41.35 | 1,46,370 | 27.41 | 1.02% | 85.80% | 115.00% | 6,295 | 3,540 | |
| 2,697.00 | 38.77 | 1,15,721 | 13.42 | 2.04% | 32.90% | 42.90% | 4,392 | 2,981 | |
| 533.55 | 35.57 | 1,08,675 | 14.38 | 15.33% | 43.00% | 56.50% | 5,092 | 3,054 | |
| 1,050.00 | 41.47 | 67,204 | 14.09 | 0.90% | 34.50% | 43.80% | 3,007 | 1,617 | |
| 935.50 | 27.39 | 27,069 | 6.97 | 2.75% | 25.20% | 32.20% | 1,883 | 987 | |
| 1,895.90 | 41.49 | 12,258 | 10.06 | 0.37% | 26.70% | 26.60% | 1,073 | 294 | |
| 836.05 | 22.37 | 10,747 | 2.43 | 4.73% | 10.30% | 15.60% | 1,906 | 513 | |
| Median 7 companies | 1,050.00 | 38.77 | 67,204 | 13.42 | 2.04% | 32.90% | 42.90% | 3,007 | 1,617 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 88
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 57
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 27
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 80
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 27
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 57
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.4%
- Company has been maintaining a healthy dividend payout of 66.6%
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 4 | 6 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 54.55
- Neutral
- MACD (12,26,9)
- −4.48
- Bullish
- SMA (50)
- 957.80
- Bearish
- SMA (200)
- 998.65
- Bearish
As of
Analyst Rating
10 of 15 analysts rate Buy, 4 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +11.33% |
|---|---|
| 3Y | +15.08% |
| 1Y | +3.73% |
| TTM | +5.67% |
Net profit
| 5Y | +13.14% |
|---|---|
| 3Y | +17.83% |
| 1Y | +4.73% |
| TTM | +1.75% |
Operating cash flow
| 5Y | +9.66% |
|---|---|
| 3Y | +22.94% |
| 1Y | +14.69% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +2.86 pp |
|---|---|
| 3Y | +2.63 pp |
| 1Y | −0.92 pp |
| TTM | −2.42 pp |
Revenue by year
| Mar 2017 | ₹1,013 Cr |
|---|---|
| Mar 2018 | ₹1,324 Cr |
| Mar 2019 | ₹1,407 Cr |
| Mar 2020 | ₹1,235 Cr |
| Mar 2021 | ₹1,202 Cr |
| Mar 2022 | ₹1,405 Cr |
| Mar 2023 | ₹1,349 Cr |
| Mar 2024 | ₹1,636 Cr |
| Mar 2025 | ₹1,982 Cr |
| Mar 2026 | ₹2,056 Cr |
Net profit by year
| Mar 2017 | ₹223 Cr |
|---|---|
| Mar 2018 | ₹349 Cr |
| Mar 2019 | ₹447 Cr |
| Mar 2020 | ₹494 Cr |
| Mar 2021 | ₹526 Cr |
| Mar 2022 | ₹673 Cr |
| Mar 2023 | ₹596 Cr |
| Mar 2024 | ₹780 Cr |
| Mar 2025 | ₹931 Cr |
| Mar 2026 | ₹975 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Aditya Birla Sun Life AMC trades at a PE of 27.06x with a market cap of ₹26,741 Cr as of 2026-11-17. The company is virtually debt-free (debt-to-equity of 0.02), carries a strong ROE of 24.13%, and has delivered 3-year compounded profit growth of 18%, though TTM profit growth has slowed to 2%.
- Nearly debt-free balance sheet with a debt-to-equity ratio of just 0.02, providing significant financial flexibility and resilience through market cycles
- Consistently high return on equity — 5-year average ROE of 27% and 10-year average of 29% — indicating efficient capital deployment in a capital-light business model
- Healthy dividend payout ratio of 66.6% with a current dividend yield of 2.84%, offering meaningful income to shareholders in a sector where many peers retain more earnings
- Strong 3-year compounded profit growth of 18% and sales growth of 15%, reflecting the broader structural shift of Indian household savings toward mutual funds
- Stock has delivered a 1-year CAGR of 25% and 3-year CAGR of 26%, significantly outperforming broader market indices over these periods
- ROCE of 30.57% underscores the asset-light nature of the AMC business, where incremental AUM growth requires minimal reinvestment in fixed assets
- TTM profit growth has decelerated sharply to just 2%, a steep drop from the 3-year compounded rate of 18%, signalling possible margin pressure or AUM growth slowdown
- TTM revenue growth of only 6% compared to 3-year compounded sales growth of 15% suggests momentum is fading in recent quarters
- PE of 27.06x is elevated relative to the sluggish TTM earnings growth of 2%, implying the stock may be pricing in a recovery that is not yet visible in reported numbers
- 5-year stock CAGR of only 10% — well below the 3-year CAGR of 26% — highlights that longer-term shareholders have experienced more muted returns
- Last year ROE of 25% has dipped from the 5-year average of 27% and the 10-year average of 29%, suggesting a gradual erosion in profitability metrics
- The AMC industry faces ongoing regulatory pressure on total expense ratios, which can compress fee income and directly impact operating margins for all fund houses
- 5-year compounded profit growth of 13% lags the 3-year figure of 18%, and the sharp TTM deceleration to 2% raises the question of whether the higher growth phase was cyclical rather than structural
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: ABSLAMC is scaling AUM aggressively with 140% YoY growth led by alternate assets, but profitability is under pressure as employee costs surged 33% and net profit declined 8% YoY. Revenue growth at 5% is not keeping pace with cost inflation. The key question going forward is whether the massive AUM expansion can translate into stronger revenue and margin recovery in coming quarters.
- Net profit drops 8% YoY Oct 22
Q2FY27 net profit fell 8% YoY to ₹221 crore despite revenue growth, indicating margin pressure.
- Employee costs surge 33% YoY Oct 22
Employee benefit expenses jumped 33% YoY in Q2FY27, significantly pressuring operating margins.
- AUM surges 140% YoY Oct 22
Overall average AUM surged 140% YoY to ₹11,056 billion in Q2FY27, driven by strong alternate assets growth.
- Revenue grows 5% YoY Oct 22
Revenue from operations rose 5% YoY to ₹484 crore in Q2FY27, reflecting steady topline expansion.
- Investor meet on Nov 18 Nov 12
ABSLAMC will participate in an annual investor conference on November 18, 2026, in Mumbai.
- RTA office shifts to Hyderabad Nov 6
RTA KFin Technologies will relocate its corporate office to Hyderabad effective December 1, 2026.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 335 | 341 | 366 | 387 | 424 | 445 | 429 | 447 | 461 | 478 | 458 | 463 | 484 |
| Expenses | 143 | 147 | 161 | 166 | 174 | 171 | 185 | 181 | 179 | 188 | 192 | 205 | 216 |
| Operating Profit | 192 | 194 | 205 | 220 | 250 | 274 | 244 | 266 | 283 | 290 | 266 | 258 | 268 |
| OPM % | 57% | 57% | 56% | 57% | 59% | 62% | 57% | 59% | 61% | 61% | 58% | 56% | 55% |
| Other Income | 56 | 80 | 74 | 95 | 96 | 38 | 72 | 118 | 45 | 84.32 | −33 | 162 | 42 |
| Interest | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 9 | 9 | 10 | 9 | 10 | 11 | 10 | 10 | 11 | 12 | 13 | 13 | 13 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | −2.82 | — | — | — |
| PBT | 237 | 264 | 268 | 305 | 335 | 300 | 305 | 372 | 316 | 358 | 219 | 406 | 296 |
| Tax % | 25% | 21% | 22% | 23% | 28% | 25% | 25% | 26% | 24% | 25% | 15% | 24% | 25% |
| Net Profit | 178 | 209 | 208 | 236 | 242 | 224 | 228 | 277 | 241 | 270 | 187 | 309 | 221 |
| EPS (₹) | 6.18 | 7.27 | 7.23 | 8.18 | 8.41 | 7.78 | 7.91 | 9.60 | 8.36 | 9.33 | 6.48 | 10.70 | 7.64 |
| YoY Sales growth | 8 | 9 | 23 | 24 | 27 | 30 | 17 | 16 | 9 | 7 | 7 | 3 | 5 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,013 | 1,324 | 1,407 | 1,235 | 1,202 | 1,405 | 1,349 | 1,636 | 1,982 | 2,056 | 1,883 |
| Expenses | 670 | 771 | 723 | 532 | 467 | 473 | 521 | 592 | 696 | 740 | 801 |
| Operating Profit | 344 | 552 | 684 | 703 | 735 | 932 | 828 | 1,044 | 1,287 | 1,316 | 1,082 |
| OPM % | 34% | 42% | 49% | 57% | 61% | 66% | 61% | 64% | 65% | 64% | 57% |
| Other Income | 1 | 0 | 0 | 0 | 4 | 3 | 5 | 5 | 4 | 1 | 253 |
| Interest | 0 | 5 | 6 | 6 | 6 | 5 | 4 | 6 | 6 | 5 | 5 |
| Depreciation | 8 | 26 | 32 | 37 | 37 | 36 | 34 | 35 | 40 | 46 | 51 |
| PBT | 337 | 522 | 646 | 661 | 696 | 895 | 794 | 1,008 | 1,245 | 1,266 | 1,280 |
| Tax % | 34% | 33% | 31% | 25% | 24% | 25% | 25% | 23% | 25% | 23% | — |
| Net Profit | 223 | 349 | 447 | 494 | 526 | 673 | 596 | 780 | 931 | 975 | 987 |
| EPS (₹) | 7.75 | 12.10 | 15.51 | 17.17 | 18.27 | 23.36 | 20.71 | 27.09 | 32.26 | 33.76 | 34.15 |
| Div. Payout % | 22% | 57% | 67% | 67% | 27% | 49% | 50% | 50% | 74% | 76% | — |
| Sales growth | — | 31 | 6 | −12 | −3 | 17 | −4 | 21 | 21 | 4 | 6 |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 144 | 144 | 144 | 144 | 144 | 145 |
| Reserves | 924 | 1,120 | 1,203 | 1,299 | 1,687 | 2,052 | 2,373 | 3,025 | 3,583 | 3,897 | 3,737 |
| Borrowings | 0 | 70 | 72 | 62 | 59 | 54 | 48 | 79 | 68 | 64 | 61 |
| Other Liabilities | 258 | 342 | 206 | 193 | 221 | 184 | 223 | 254 | 320 | 310 | 300 |
| Total Liabilities | 1,200 | 1,549 | 1,498 | 1,572 | 1,985 | 2,435 | 2,788 | 3,502 | 4,114 | 4,415 | 4,242 |
| Fixed Assets | 18 | 90 | 95 | 86 | 77 | 72 | 70 | 111 | 107 | 116 | 111 |
| CWIP | 0 | 0 | 2 | 1 | 1 | 3 | 2 | 2 | 1 | 5 | 0 |
| Investments | 901 | 1,141 | 1,138 | 1,263 | 1,726 | 2,121 | 2,359 | 3,122 | 3,692 | 3,946 | 3,812 |
| Other Assets | 281 | 318 | 263 | 221 | 180 | 239 | 357 | 267 | 315 | 348 | 319 |
| Total Assets | 1,200 | 1,549 | 1,498 | 1,572 | 1,985 | 2,435 | 2,788 | 3,502 | 4,114 | 4,415 | 4,242 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 346 | 315 | 497 | 512 | 563 | 437 | 685 | 708 | 812 |
| Investing | 0 | −69 | 62 | −66 | −340 | −298 | −134 | −511 | −305 | −95 |
| Financing | 0 | −259 | −384 | −423 | −162 | −256 | −335 | −169 | −399 | −703 |
| Net Cash Flow | 0 | 18 | −6 | 8 | 10 | 9 | −32 | 5 | 5 | 15 |
| Free Cash Flow | 0 | 330 | 295 | 481 | 502 | 547 | 419 | 655 | 678 | 766 |
| CFO/EBITDA | 0 | 89 | 79 | 95 | 90 | 86 | 75 | 83 | 78 | 86 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 12 | 7 | 12 | 9 | 7 | 7 | 9 | 11 | 10 |
| Cash Conversion Cycle | 20 | 12 | 7 | 12 | 9 | 7 | 7 | 9 | 11 | 10 |
| Working Capital Days | −18 | −10 | 7 | −1 | −25 | −5 | 11 | −2 | −5 | −9 |
| ROCE % | — | 49% | 52% | 50% | 45% | 45% | 33% | 35% | 36% | 32% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aditya Birla Sun Life AMC insights
53 extracted metrics across FY17–FY27.
Documents
- Q2 FY27 concall · Oct 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · Apr 2026Transcript PPT Recording
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Q2 FY26 concall · Oct 2025Transcript PPT Recording
- 21 Oct 2026
- 14 Oct 2026
- 27 Mar 2026
- 4 Feb 2026
- 16 Oct 2025
- General announcements 12 Nov 2026
- General announcements 6 Nov 2026
Frequently Asked Questions about Aditya Birla Sun Life AMC
What does Aditya Birla Sun Life AMC Ltd do?
Where is Aditya Birla Sun Life AMC Ltd (ABSLAMC) listed?
Which sector does Aditya Birla Sun Life AMC Ltd belong to?
What is the market capitalisation of Aditya Birla Sun Life AMC Ltd?
What is the PE ratio of Aditya Birla Sun Life AMC Ltd?
What is the 52-week high and low of Aditya Birla Sun Life AMC Ltd?
Does Aditya Birla Sun Life AMC Ltd pay dividends?
What is the Return on Equity (ROE) of Aditya Birla Sun Life AMC Ltd?
Company Information
Incorporated in 1994, Aditya Birla Sun Life AMC is set up as a joint venture between Aditya Birla Capital Ltd and Sun Life AMC. The Co. offers Mutual Fund services, Portfolio Management services, offshore and real estate offerings.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ABSLAMC.md for Aditya Birla Sun Life AMC Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.